Drug-related low responsiveness to recombinant human erythropoietin therapy in three patients with end-stage renal disease.
Ikeda
Y
Y
Sakemi
T
T
Ohtsuka
Y
Y
Kuwahara
M
M
Fujisaki
N
N
D000368:Aged; D000493:Allopurinol / Q000009:adverse effects; D000740:Anemia / Q000628:therapy*; D002216:Captopril / Q000009:adverse effects; D004347:Drug Interactions; D004351:Drug Resistance; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000009:adverse effects; D011994:Recombinant Proteins
D010880:Piperidines; D011994:Recombinant Proteins; D004921:Erythropoietin; D000493:Allopurinol; D002216:Captopril; C053742:roxatidine acetate